Warnings fluoroquinolone outweighs the risk fluoroquinolones. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Organisms36

Streptococcus pneumoniae Staphylococcus aureus Gram-Negative Bacteria Escherichia coli Gram-Positive Bacteria Mycoplasma hominis Pseudomonas aeruginosa Mycobacterium tuberculosis Clostridium difficile Neisseria gonorrhoeae Salmonella typhi Salmonella enterica Mycobacterium fortuitum Bacteria, Anaerobic Klebsiella pneumoniae Salmonella paratyphi A Campylobacter jejuni Bacteria Campylobacter Enterobacteriaceae Gram-Positive Cocci Campylobacter coli Moraxella (Branhamella) catarrhalis Mycobacterium smegmatis Bacteroides fragilis Enterococcus faecalis Acinetobacter Haemophilus influenzae Laurus Bartonella bacilliformis Salmonella Methicillin-Resistant Staphylococcus aureus Staphylococcus Streptococcus pyogenes Serratia marcescens Ureaplasma

Diseases34

Dermatitis, Phototoxic Gram-Negative Bacterial Infections Escherichia coli Infections Pneumococcal Infections Bacterial Infections Urinary Tract Infections Community-Acquired Infections Typhoid Fever Eye Infections, Bacterial Tuberculosis, Multidrug-Resistant Dermatitis, Photoallergic Gonorrhea Cross Infection Paratyphoid Fever Campylobacter Infections Pseudomonas Infections Respiratory Tract Infections Enterocolitis, Pseudomembranous Salmonella Infections Gram-Positive Bacterial Infections Bacteremia Staphylococcal Infections Extensively Drug-Resistant Tuberculosis Klebsiella Infections Pneumonia, Bacterial Bronchitis, Chronic Tuberculosis Pneumonia, Pneumococcal Enterobacteriaceae Infections Streptococcal Infections Otitis Externa Poultry Diseases Clostridium Infections Corneal Ulcer

Chemicals and Drugs55

Fluoroquinolones Anti-Infective Agents DNA Gyrase Ciprofloxacin Ofloxacin DNA Topoisomerase IV Aza Compounds Levofloxacin Quinolones Anti-Bacterial Agents Norfloxacin Naphthyridines Pefloxacin Quinolines Enoxacin DNA Topoisomerases, Type II 4-Quinolones Nalidixic Acid Topoisomerase II Inhibitors DNA, Bacterial Fleroxacin Macrolides Antitubercular Agents beta-Lactams Bacterial Proteins DNA Topoisomerases Aminoglycosides Anti-Infective Agents, Urinary Dioxolanes Cephalosporins beta-Lactamases Membrane Transport Proteins Erythromycin Reserpine Nitrofurantoin Trimethoprim-Sulfamethoxazole Combination Ethambutol Lactams Capreomycin Streptogramin B Multidrug Resistance-Associated Proteins Carbapenems Ethidium Rifampin Piperazines Ceftriaxone Azithromycin Culture Media Escherichia coli Proteins Penicillins Bacterial Outer Membrane Proteins Chloramphenicol Ampicillin Tetracyclines DNA, Superhelical

Analytical, Diagnostic and Therapeutic Techniques and Equipment26

Microbial Sensitivity Tests Drug Labeling Area Under Curve Electrophoresis, Gel, Pulsed-Field Sequence Analysis, DNA Vital Signs Colony Count, Microbial Amino Acid Substitution Polymerase Chain Reaction Ribotyping Disk Diffusion Antimicrobial Tests Antibiotic Prophylaxis Population Surveillance Administration, Oral Retrospective Studies Molecular Typing Drug Therapy, Combination Treatment Failure Culture Media Reverse Transcriptase Polymerase Chain Reaction Risk Factors Bacterial Typing Techniques Chromatography, Supercritical Fluid Serum Bactericidal Test Serotyping Treatment Outcome

Phenomena and Processes21

Drug Resistance, Bacterial Drug Resistance, Microbial Drug Resistance, Multiple, Bacterial Mutation Drug Resistance, Multiple Area Under Curve Genes, Bacterial Amino Acid Substitution Drug Interactions beta-Lactam Resistance Methicillin Resistance Cephalosporin Resistance Penicillin Resistance Plasmids Mutation, Missense Point Mutation Time Factors Dose-Response Relationship, Drug Genotype Phenotype DNA, Superhelical

Anthropology, Education, Sociology and Social Phenomena1

United States Food and Drug Administration

Technology, Industry, Agriculture5

Product Labeling Product Packaging Drug Labeling Tobacco Products Advertising as Topic

Information Science3

Molecular Sequence Data Formularies, Hospital Advertising as Topic

Named Groups1

Health Care12

Drug Utilization Area Under Curve Hospitals Consumer Product Safety United States Food and Drug Administration Population Surveillance Retrospective Studies Disease Outbreaks Treatment Failure Risk Factors Hospitals, County Treatment Outcome

Geographicals4

United States France Taiwan Canada

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Fluoroquinolones Anti-Infective Agents DNA Gyrase Ciprofloxacin Ofloxacin DNA Topoisomerase IV Aza Compounds Levofloxacin Microbial Sensitivity Tests Drug Resistance, Bacterial Quinolones Anti-Bacterial Agents Norfloxacin Naphthyridines Pefloxacin Product Labeling Quinolines Drug Resistance, Microbial Enoxacin DNA Topoisomerases, Type II 4-Quinolones Drug Resistance, Multiple, Bacterial Streptococcus pneumoniae Nalidixic Acid Dermatitis, Phototoxic Topoisomerase II Inhibitors Product Packaging Drug Labeling Mutation Staphylococcus aureus Gram-Negative Bacteria DNA, Bacterial Escherichia coli Fleroxacin Gram-Negative Bacterial Infections Gram-Positive Bacteria Macrolides Antitubercular Agents Escherichia coli Infections Pneumococcal Infections Drug Utilization Bacterial Infections Mycoplasma hominis Pseudomonas aeruginosa beta-Lactams Bacterial Proteins DNA Topoisomerases Mycobacterium tuberculosis Urinary Tract Infections Community-Acquired Infections Typhoid Fever Clostridium difficile Drug Resistance, Multiple Eye Infections, Bacterial Neisseria gonorrhoeae Salmonella typhi Aminoglycosides Tuberculosis, Multidrug-Resistant Salmonella enterica Mycobacterium fortuitum Dermatitis, Photoallergic Bacteria, Anaerobic Anti-Infective Agents, Urinary Gonorrhea Klebsiella pneumoniae Cross Infection Salmonella paratyphi A Area Under Curve Dioxolanes Paratyphoid Fever Campylobacter jejuni Campylobacter Infections Genes, Bacterial Bacteria Pseudomonas Infections Cephalosporins Respiratory Tract Infections beta-Lactamases Electrophoresis, Gel, Pulsed-Field Campylobacter Membrane Transport Proteins Enterocolitis, Pseudomembranous Salmonella Infections Gram-Positive Bacterial Infections Tobacco Products Enterobacteriaceae Gram-Positive Cocci Sequence Analysis, DNA Campylobacter coli Erythromycin Bacteremia Staphylococcal Infections Vital Signs Colony Count, Microbial Reserpine Extensively Drug-Resistant Tuberculosis Hospitals Moraxella (Branhamella) catarrhalis Nitrofurantoin Consumer Product Safety

No FAQ available that match "warnings fluoroquinolone outweighs the risk fluoroquinolones"